Clinical Trials Directory

Trials / Completed

CompletedNCT01937247

Redesigned Process in the Operating Room

Redesigned Process in the Operating Room: Monitoring and Evaluating Success of Reducing Non Operative Time

Status
Completed
Phase
Phase 2 / Phase 3
Study type
Interventional
Enrollment
120 (actual)
Sponsor
American University of Beirut Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

The main purpose of the study is to examine whether operating room (OR) efficiency will be improved by significantly decreasing non operative time. This study also aims: 1) to evaluate whether a decrease in non-operative time will result in increased surgeon and staff satisfaction, 2) to determine whether there is an increase in the complication rate during the redesigned process perioperatively and until discharge from the post anesthesia care unit, and 3) to rate patient satisfaction.

Detailed description

The study aims to examine whether operating room efficiency will be improved by decreasing non operative time while ensuring patient safety. Patients will be randomized into one of two groups: In group A (new process): patients will be inducted in the induction room. At the end of surgery and after placement of the surgical dressing, the registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room. The patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR. In group B (the current practice at AUBMC), patients will be treated as follows: patients will be induced in the operating room and at the end of surgery will be reversed with neostigmine 50µg/kg and glycopyrrolate 10µg/kg. Once extubated and rolled out of the room, the house keeper team will start cleaning the operating room. Induction time (IT), emergence time (ET), and turn over time (TOT) will be recorded for both groups. We expect to show that OR efficiency will be improved by significantly decreasing non operative time while ensuring patient safety.

Conditions

Interventions

TypeNameDescription
PROCEDUREPatients will be inducted in the induction roomThe patients will be inducted in the induction room
PROCEDURERedesigned processThe registered nurse will call in the house keeper to start cleaning of the OR (parallel processing) before the patient exits the room
DRUGpatient will be reversed with sugammadex 4mg/kg IVThe patient will be reversed with sugammadex 4mg/kg IV, and then extubated before being moved out of the OR
PROCEDURESTANDARD PROCESSstandard process

Timeline

Start date
2018-05-18
Primary completion
2020-10-30
Completion
2020-10-30
First posted
2013-09-09
Last updated
2022-03-09

Locations

1 site across 1 country: Lebanon

Source: ClinicalTrials.gov record NCT01937247. Inclusion in this directory is not an endorsement.